AB23A decreases the level of reactive oxygen species (ROS) in the H9C2 cell line with lipopolysaccharide (LPS) stimulation. The chart shows the ROS production of normal control, LPS injection group, pre-treatment with AB23A at the concentration of 0.1 μM (LPS+AB23A-L), 1 μM (LPS+AB23A-M), and 10 μM (LPS+AB23A-H). With pre-treatment with AB23A of LPS stimulated H9C2 cells, the ROS began to decline within a certain range. ** P<0.01, versus control group. #
P<0.05 versus model group. ##
P<0.01 versus model group.